Evidence map›Paper›PMID 35908970›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin.

Kenta Hayashino, Junichi Zaitsu, Kazuya Kuraoka, Taizo Hirata

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kenta HayashinoDepartment of Hematology, Okayama City Hospital, Japan.
Junichi ZaitsuDepartment of Diagnostic Pathology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Japan.
Kazuya KuraokaDepartment of Diagnostic Pathology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Japan.
Taizo HirataDepartment of Oncology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Japan.
Kure Medical Center · JPNational Hospital Organization · JPOkayama Prefecture · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metaplastic breast cancer (MBC) is characterized by the histological presence of a mixture of epithelial and mesenchymal-like elements. However, MBC responds poorly to chemotherapy. Due to its rarity, there is no well-defined treatment for MBC. Herein, we report the case of a 56-year-old woman who underwent a mastectomy and was diagnosed with MBC with osseous differentiation classified as pT4N0M1. After the operation, she was treated with adriamycin and cisplatin, which are standard osteosarcoma treatments, resulting in a partial response. However, to determine the proper chemotherapy treatment, knowledge of the metaplastic elements of the tumor is required.

Indexed as

Bone NeoplasmsBreast NeoplasmsCisplatinDoxorubicinFemaleHumansMastectomyMiddle AgedCisplatinDoxorubicinadriamycin and cisplatinchemotherapymetaplastic breast cancerosseous/cartilaginous differentiation

Identifiers

PMID35908970
PMCPMC10017233
OpenAlexW4288468402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.